For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
The Epoch Times
What to Know About Trump’s Plan to Slash Drug Prices
The Epoch Times cited CEI’s expert on drug prices “Jeremy Nighohossian, a senior fellow at the Competitive Enterprise Institute, a libertarian think tank, told The…

Blog
GOP proposal includes reductions in health care expenditures
Over the weekend the House Committee on Energy and Commerce released a proposal describing how it would achieve the expenditure goals for the Reconciliation…

Blog
The numbers don’t add up in new Medicaid paper
In a recently released working paper, authors Angela Wyse and Bruce D. Meyer purport to show that the ACA Medicaid expansion saved 27,400 lives…
Search Posts
The Epoch Times
What to Know About Trump’s Plan to Slash Drug Prices
The Epoch Times cited CEI’s expert on drug prices “Jeremy Nighohossian, a senior fellow at the Competitive Enterprise Institute, a libertarian think tank, told The…
Blog
GOP proposal includes reductions in health care expenditures
Over the weekend the House Committee on Energy and Commerce released a proposal describing how it would achieve the expenditure goals for the Reconciliation…
Blog
The numbers don’t add up in new Medicaid paper
In a recently released working paper, authors Angela Wyse and Bruce D. Meyer purport to show that the ACA Medicaid expansion saved 27,400 lives…
Letters
CEI joins ATR Coalition Urging CRA on Medical Debt Rule
Dear Member of Congress, We are writing to express our concerns regarding the Consumer Financial Protection Bureau’s finalized rule on eliminating medical debt records from…
Blog
FTC’s second interim report on PBMs: Don’t hold your breath
The Federal Trade Commission (FTC) will consider issuing a second interim report on Pharmacy Benefit Managers (PBMs) tomorrow during its January 14 open meeting.
Blog
Congress shouldn’t rely on incomplete FTC PBM study
Lawmakers are making a last-minute push to regulate the practices of pharmacy benefit managers (PBMs) during the lame duck session. However, it would be a…